Chief Financial Officer
Ms. Li is the Chief Financial Officer of Axis Therapeutics. She also supports Athenex, Inc. in corporate development, capital raising, investor relations and project management. Prior to joining Athenex, Ms. Li was with Credit Suisse’s Investment Banking and Capital Markets division in Hong Kong, advising clients from various sectors spanning life sciences, general industrials, internet and others. Ms. Li has developed deep experience through the execution of capital markets, mergers and acquisitions, and other financing transactions, including the initial public offering of Athenex. Ms. Li graduated with a B.S. in Economics from The Wharton School, University of Pennsylvania.